The Valley Desk

ArticleVirusesPublished

The Dual-Targeted Fusion Inhibitor Clofazimine Binds to the S2 Segment of the SARS-CoV-2 Spike Protein

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Thomas Jefferson University. Affiliation source

Publication record

Type
Article
Venue
Viruses
Published
Subject terms
Humans; Sulfides; Indoles; Clofazimine; Antiviral Agents; Surface Plasmon Resonance; Binding Sites; Protein Binding; Structure-Activity Relationship; Molecular Docking Simulation; Spike Glycoprotein, Coronavirus; Viral Fusion Protein Inhibitors
PubMed ID
38675980
PubMed Central ID
PMC11054727
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal